Tianying Zhang
Xiamen, 361005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Integrating Multi-Source Directed Gene Networks and Multi-Omics Data to Identify Cancer Driver Genes Based on Graph Neural Networks.
Journal: International journal of molecular sciences
Published: November 05, 2025
Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 25, 2025
Liposomal simvastatin potentiates intranasal H1N1 influenza subunit vaccine via increasing transcytosis of antigen and submucosal dendritic cell recruitment.
Journal: Acta pharmaceutica Sinica. B
Published: June 26, 2025
Development of COVID-19 Vaccine Candidates Using Attenuated Recombinant Vesicular Stomatitis Virus Vectors with M Protein Mutations.
Journal: Viruses
Published: May 23, 2025
Krüppel-like factor 2 programs early exhausted T cell states and restrains antiviral immunity.
Journal: Immunity
Published: March 31, 2025
An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutation.
Journal: iScience
Published: March 01, 2025
TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models.
Journal: Emerging microbes & infections
Published: August 07, 2024
A respiratory mucosal vaccine based on chitosan/aluminum adjuvant induces both mucosal and systemic immune responses.
Journal: International journal of pharmaceutics
Published: June 29, 2024
A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants.
Journal: Cell reports methods
Published: February 05, 2024
Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 23, 2023
Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity.
Journal: Cancer immunology research
Published: November 03, 2023
Last Updated: 09/26/2026